— Know what they know.
Not Investment Advice

PGEN NASDAQ

Precigen, Inc.
1W: -7.0% 1M: +8.1% 3M: -2.3% YTD: +0.0% 1Y: +203.6% 3Y: +250.8% 5Y: -38.1%
$4.24
-0.04 (-0.93%)
 
Weekly Expected Move ±8.4%
$4 $4 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 61 · $1.3B mcap · 124M float · 3.50% daily turnover · Short 49% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$10M +146.7% ▲
5Y CAGR: -21.3%
Gross Profit
$4M +1149.1% ▲
Operating Income
-$107M +21.1% ▲
Net Income
-$251M -98.6% ▼
EPS (Diluted)
$-1.41 -200.0% ▼
EBITDA
-$103M +16.3% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$14M$27M$6M$4M$10M
YoY Growth-55.4%+88.6%-76.9%-36.9%+146.7%
Cost of Revenue$54M$6M$6M$4M$6M
Gross Profit-$39M$21M$106K-$342K$4M
Gross Margin-276.2%76.4%1.7%-8.7%37.1%
R&D Expenses$48M$47M$49M$53M$41M
SG&A Expenses$0$48M$40M$41M$70M
Operating Expenses$53M$96M$100M$135M$110M
Operating Income-$92M-$76M-$100M-$135M-$107M
Operating Margin-644.5%-281.4%-1602.5%-3440.2%-1100.8%
Interest Expense$19M$7M$468K$6K$4M
Income Before Tax-$111M-$80M-$96M-$128M-$251M
Tax Expense-$160K-$189K-$458K-$2M$3K
Net Income-$92M$28M-$96M-$126M-$251M
Net Margin-646.0%105.2%-1540.6%-3216.2%-2588.2%
EPS (Diluted)$-0.47$-0.33$-0.39$-0.47$-1.41
EBITDA-$78M-$62M-$89M-$123M-$103M
Shares Outstanding198M200M245M268M305M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms